Feb 18, 2026Gene Therapy for Telomere Biology Disorders: EXG-34217 Trial Results at Cincinnati Children'sEXG-34217, a gene therapy delivering functional TERT, showed telomere elongation and hematopoietic recovery in two patients with dyskeratosis congenita — a rare inherited disease, not general aging. Results published in NEJM Evidence.